Barrington Research Forecasts Strong Price Appreciation for Option Care Health (NASDAQ:OPCH) Stock

Option Care Health (NASDAQ:OPCH) had its price objective lifted by equities researchers at Barrington Research from $32.00 to $33.00 in a report issued on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Barrington Research’s target price indicates a potential upside of 16.61% from the stock’s previous close.

OPCH has been the subject of a number of other research reports. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and lowered their price objective for the company from $38.00 to $26.00 in a research report on Thursday, October 31st. JMP Securities reissued a “market outperform” rating and issued a $30.00 price target (down from $31.00) on shares of Option Care Health in a research note on Friday. Truist Financial lowered their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Finally, UBS Group assumed coverage on shares of Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and an average target price of $29.86.

Option Care Health Stock Up 2.1 %

NASDAQ:OPCH traded up $0.58 during trading hours on Tuesday, hitting $28.30. 1,480,635 shares of the company’s stock traded hands, compared to its average volume of 1,988,855. The firm has a market cap of $4.82 billion, a P/E ratio of 23.78, a P/E/G ratio of 2.43 and a beta of 1.31. The stock’s fifty day moving average price is $23.20 and its two-hundred day moving average price is $27.69. Option Care Health has a twelve month low of $21.39 and a twelve month high of $34.63. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.

Insider Activity

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the company’s stock in a transaction dated Friday, November 8th. The stock was bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the acquisition, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. 0.64% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. UMB Bank n.a. boosted its position in Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after purchasing an additional 750 shares during the period. GAMMA Investing LLC lifted its position in shares of Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. grew its holdings in Option Care Health by 3,362.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after purchasing an additional 1,446 shares during the period. International Assets Investment Management LLC grew its position in Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after purchasing an additional 2,757 shares during the last quarter. Finally, Quarry LP boosted its position in shares of Option Care Health by 327.7% during the third quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after buying an additional 2,628 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.